Person:
ERENBERK, UFUK

Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
UFUK
Last Name
ERENBERK
Name
Email Address
Birth Date

Filters

2020 - 20227
Reset filters

Settings

Item Type: Publication × Has files: false × Start date: 2020 × End date: 2022 ×

Search Results

Now showing 1 - 7 of 7
  • No Thumbnail Available
    PublicationMetadata only
    Short-term efficacy of ORS formulation and propranolol regimen in children with POTS
    (2020-08-01T00:00:00Z) YOZGAT, Yılmaz; OTÇU TEMUR, Hafize; Coban, Senay; Oner, Taliha; Karaarslan, Utku; Yozgat, Can Yilmaz; Karadeniz, Cem; ERGÖR, Serap Nur; ERENBERK, UFUK; YOZGAT, YILMAZ; OTÇU TEMUR, HAFİZE; ERGÖR, SERAP NUR; ERENBERK, UFUK
    Background: To evaluate the short-term effectiveness of reduced-osmolarity oral rehydration salt formulation (ORS) and propranolol in children diagnosed with postural orthostatic tachycardia syndrome (POTS) in head-up tilt testing (HUTT).
  • No Thumbnail Available
    PublicationMetadata only
    Human Paraoxonase-1 Activity in Children with Acute Bronchiolitis
    (2020-03-01) ERENBERK U.; USTABAŞ KAHRAMAN F.; ÖZKAYA E.; NURSOY M. A.; DOĞAN DEMİR A.; TÜREL Ö.; ERENBERK, UFUK; USTABAŞ KAHRAMAN, FEYZA; NURSOY, MUSTAFA ATİLLA; DOĞAN DEMİR, AYŞEGÜL; TÜREL, ÖZDEN
    INTRODUCTION: Human paraoxonase-1 (PON1) is one of the endogenous antioxidant molecules working against oxidative stress. We aimed to investigate serum PON1 activity in children with acute bronchiolitis.
  • No Thumbnail Available
    PublicationMetadata only
    Bewertung der Funktionen des rechten Herzens bei Kindern mit leichter Mukoviszidose.
    (2021-02-18T00:00:00Z) Guliyeva, Aynur; Cakir, Erkan; Yazan, Hakan; AlShadfan, Lina; Sharifov, Rasul; Temur, Hafize Otcu; Karaarslan, Utku; Yozgat, Can Yilmaz; Yakut, Kahraman; Yozgat, YILMAZ; ÇAKIR, ERKAN; ERENBERK, UFUK; YOZGAT, YILMAZ
  • No Thumbnail Available
    PublicationMetadata only
    A Snapshot of Pediatric Patients with COVID-19 in a Pandemic Hospital
    (2020-10-01T00:00:00Z) BURSAL DURAMAZ, BURCU; TÜREL, Özden; KORKMAZ, ÇİĞDEM; KARADOĞAN, MUHAMMED TALHA; Yozgat, Can Yilmaz; İŞCAN, AKIN; SÜMBÜL, BİLGE; ERENBERK, UFUK; BURSAL DURAMAZ, BURCU; TÜREL, ÖZDEN; KORKMAZ, ÇİĞDEM; KARADOĞAN, MUHAMMED TALHA; İŞCAN, AKIN; SÜMBÜL, BİLGE; ERENBERK, UFUK
    Aim Reports describing coronavirus disease 2019 (Covid-19) in children are fewer than adult studies due to milder clinical picture. We aimed to share our experience at a single center with an emphasis on collective decision making.
  • No Thumbnail Available
    PublicationMetadata only
    Human paraoxonase-1 activity in children with acute bronchiolitis Akut bronşiolitli çocuklarda human paraoksonaz-1 aktivitesi
    (2020-01-01T00:00:00Z) ERENBERK, UFUK; Kahraman, Feyza Ustabaş; Özkaya, Emin; NURSOY, MUSTAFA ATİLLA; Demir, Ayşegül Doğan; TÜREL, Özden; ERENBERK, UFUK; ÖZKAYA, EMİN; NURSOY, MUSTAFA ATİLLA; TÜREL, ÖZDEN
    © 2020, Galenos. All rights reserved.INTRODUCTION: Human paraoxonase-1 (PON1) is one of the endogenous antioxidant molecules working against oxidative stress. We aimed to investigate serum PON1 activity in children with acute bronchiolitis. MATERIALS and METHODS: A total of 29 children aged between 3-21 months with acute bronchiolitis and 35 age-matched healthy controls were included in the study. Bronchiolitis patients were further classified as mild (65%) and moderate (35%). Paraoxonase and arylesterase activities of PON1 were compared between patients with acute bronchiolitis and the control group. RESULTS: Paraoxonase activity of children with acute bronchiolitis was lower than healthy controls but the difference was not significant (127.53 ± 64.17 U/L versus 153.95 ± 74.40 U/L) (p=0.13). Arylesterase activity was significantly decreased in children with mild and moderate bronchiolitis in comparison to the control group (142.43± 56.60 kU/L and 103.70± 26.03 kU/L versus 201.09± 57.26 kU/L) (p<0.001). CONCLUSIONS: Serum PON1 activity was lower in children with acute bronchiolitis compared to controls. Increasing antioxidant capacity may be an effective means of therapy in viral induced lung disease.
  • No Thumbnail Available
    PublicationMetadata only
    Kardiyak Rabdomiyomu Olmayan Tuberous SklerozluHastalarda Kardiyak Aritmilerin ElektrokardiyografikBelirteçlerle Değerlendirilmesi
    (2020-03-02T00:00:00Z) YOZGAT, YILMAZ; KUŞ, HAZAR DOĞUŞ; Yozgat, Can Yılmaz; USTABAŞ KAHRAMAN, FEYZA; Yüksel, Mine; YAKUT, KAHRAMAN; İşçan, Akın; ERENBERK, UFUK; YOZGAT, YILMAZ; KUŞ, HAZAR DOĞUŞ; USTABAŞ KAHRAMAN, FEYZA; YAKUT, KAHRAMAN; ERENBERK, UFUK
  • No Thumbnail Available
    PublicationMetadata only
    The Success of the Cystic Fibrosis Registry of Turkey for Improvement of Patient Care.
    (2022-01-31T00:00:00Z) Erenberk, Ufuk; Sismanlar Eyuboglu, Tugba; Aslan, Ayse Tana; Gursoy, Tugba Ramasli; Emiralioglu, Nagehan; Yalcin, Ebru; Kiper, Nural; Sen, Velat; Sen, Hadice Selimoglu; Altintas, Derya Ufuk; Ozcan, Dilek; Kilinc, Ayse Ayzit; Cokugras, Haluk; Baskan, Azer Kilic; Yazan, Hakan; Unal, Gökcen; Yilmaz, Aslı Imran; Keskin, Ozlem; Arik, Elif; Kucukosmanoglu, Ercan; Irmak, Ilim; Damadoglu, Ebru; Ozturk, Gökcen Kartal; Gulen, Figen; Basaran, Abdurrahman Erdem; Bingol, Aysen; Cekic, Sukru; Sapan, Nihat; Kilic, Gonca; Harmanci, Koray; Kose, Mehmet; Ozdemir, Ali; Tugcu, Gokcen Dilsa; Polat, Sanem Eryilmaz; Hangul, Melih; Ozcan, Gizem; Aydin, Zeynep Gokce Gayretli; Yuksel, Hasan; Topal, Erdem; Ozdogan, Sebnem; Caltepe, Gonul; Suleyman, Ayse; Can, Demet; Ekren, Pervin Korkmaz; Bal, Cem Murat; Kilic, Mehmet; Cinel, Guzin; Cobanoglu, Nazan; Pekcan, Sevgi; Cakir, Erkan; Ozcelik, Ugur; Prof, Deniz Dogru; ERENBERK, UFUK; DOĞAN, GÜZİDE; ÇAKIR, ERKAN